DK0788480T3 - Krystallisering af levobupivacain og analoger deraf - Google Patents

Krystallisering af levobupivacain og analoger deraf

Info

Publication number: DK0788480T3
Authority: DK; Denmark
Prior art keywords: pct; levobupivacaine; analogues; crystallization; sec
Prior art date: 1994-10-25

Application number

DK95934738T

Other languages

English (en)

Inventor

Marianne Langston

Benjamin Mark Skead

Original Assignee

Darwin Discovery Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-25

Filing date

1995-10-23

Publication date

2003-09-29

1994-10-25 Priority claimed from GB9421476A external-priority patent/GB9421476D0/en

1995-03-10 Priority claimed from GBGB9504926.8A external-priority patent/GB9504926D0/en

1995-10-23 Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd

2003-09-29 Application granted granted Critical

2003-09-29 Publication of DK0788480T3 publication Critical patent/DK0788480T3/da

Links

238000002425 crystallisation Methods 0.000 title 1
230000008025 crystallization Effects 0.000 title 1
LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 title 1
229960004288 levobupivacaine Drugs 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 2
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
235000002906 tartaric acid Nutrition 0.000 abstract 1
239000011975 tartaric acid Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Compounds Of Unknown Constitution (AREA)
Saccharide Compounds (AREA)
Epoxy Compounds (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK95934738T 1994-10-25 1995-10-23 Krystallisering af levobupivacain og analoger deraf DK0788480T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9421476A GB9421476D0 (en)	1994-10-25	1994-10-25	Process and salt
GBGB9504926.8A GB9504926D0 (en)	1995-03-10	1995-03-10	Crystallisation
PCT/GB1995/002513 WO1996012699A1 (en)	1994-10-25	1995-10-23	Crystallisation of levobupivacaine and analogues thereof

Publications (1)

Publication Number	Publication Date
DK0788480T3 true DK0788480T3 (da)	2003-09-29

Family

ID=26305863

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95934738T DK0788480T3 (da)	1994-10-25	1995-10-23	Krystallisering af levobupivacain og analoger deraf

Country Status (16)

Country	Link
US (1)	US5994548A (da)
EP (1)	EP0788480B1 (da)
JP (1)	JP3911545B2 (da)
AT (1)	ATE245629T1 (da)
AU (1)	AU698637B2 (da)
CA (1)	CA2200355C (da)
DE (1)	DE69531356T2 (da)
DK (1)	DK0788480T3 (da)
ES (1)	ES2202375T3 (da)
FI (1)	FI117438B (da)
HU (1)	HU227420B1 (da)
MX (1)	MX9703024A (da)
NO (1)	NO309266B1 (da)
PL (1)	PL183210B1 (da)
PT (1)	PT788480E (da)
WO (1)	WO1996012699A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0002246A (pt) *	2000-04-06	2003-04-15	Cristalia Prod Quimicos Farm	Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
BRPI0104491B8 (pt) *	2001-10-10	2021-05-25	Cristalia Produtos Quim Farmaceuticos Ltda	n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en)	2002-06-25	2004-01-01	Guohua Chen	Short duration depot formulations
ATE482695T1 (de)	2002-12-13	2010-10-15	Durect Corp	Orale darreichungsform mit flüssigen hochviskosen trägersystemen
US7094812B2 (en) *	2003-04-24	2006-08-22	Xerox Corporations	Colorant compositions
US6790267B1 (en) *	2003-04-24	2004-09-14	Xerox Corporation	Colorant compositions
SI2415484T1 (sl)	2004-09-17	2014-10-30	Durect Corporation	Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljĹˇanim sproĹˇÄŤanjem
US20070027105A1 (en)	2005-07-26	2007-02-01	Alza Corporation	Peroxide removal from drug delivery vehicle
WO2007123405A1 (en) *	2006-04-25	2007-11-01	Dishman Pharmaceuticals And Chemicals Ltd.	Ropivacaine hydrochloride anhydrate and the preparation thereof
AU2007325918B2 (en)	2006-11-03	2013-10-17	Durect Corporation	Transdermal delivery systems comprising bupivacaine
JP2011506319A (ja)	2007-12-06	2011-03-03	デュレクトコーポレーション	疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
PL2234974T3 (pl) *	2008-01-15	2012-09-28	Pharmathen Sa	Sposób otrzymywania związku (s)-1-alkilo-2', 6'-pipekoloksylidydu
US20100260844A1 (en)	2008-11-03	2010-10-14	Scicinski Jan J	Oral pharmaceutical dosage forms
CN103073484B (zh) *	2013-01-28	2014-10-22	山东诚创医药技术开发有限公司	一种甲哌卡因及其光学对映体的制备方法
AU2014233453A1 (en)	2013-03-15	2015-10-01	Durect Corporation	Compositions with a rheological modifier to reduce dissolution variability
US12274794B2 (en)	2016-07-06	2025-04-15	Orient Pharma Co., Ltd.	Oral dosage form with drug composition, barrier layer and drug layer
KR102442753B1 (ko) *	2016-12-26	2022-09-16	셀릭스 바이오 프라이빗 리미티드	만성 통증 치료를 위한 화합물
JP2023515918A (ja)	2020-01-13	2023-04-17	デュレクトコーポレーション	不純物が低減された徐放性薬物送達システム及び関連の方法
CA3203561A1 (en)	2021-01-12	2022-07-21	Adrian Neil Verity	Sustained release drug delivery systems and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE341404B (da) *	1967-05-18	1971-12-27	Sterling Drug Inc
US4695576A (en) *	1984-07-09	1987-09-22	Astra Lake Medel Aktiebolag	L-N-n-propylpipecolic acid-2,6-xylidide

1995
- 1995-10-23 JP JP51373896A patent/JP3911545B2/ja not_active Expired - Lifetime
- 1995-10-23 HU HU9702372A patent/HU227420B1/hu unknown
- 1995-10-23 CA CA002200355A patent/CA2200355C/en not_active Expired - Lifetime
- 1995-10-23 WO PCT/GB1995/002513 patent/WO1996012699A1/en not_active Ceased
- 1995-10-23 US US08/849,418 patent/US5994548A/en not_active Expired - Lifetime
- 1995-10-23 MX MX9703024A patent/MX9703024A/es unknown
- 1995-10-23 PL PL95319829A patent/PL183210B1/pl unknown
- 1995-10-23 ES ES95934738T patent/ES2202375T3/es not_active Expired - Lifetime
- 1995-10-23 AU AU37048/95A patent/AU698637B2/en not_active Expired
- 1995-10-23 PT PT95934738T patent/PT788480E/pt unknown
- 1995-10-23 DE DE69531356T patent/DE69531356T2/de not_active Expired - Lifetime
- 1995-10-23 DK DK95934738T patent/DK0788480T3/da active
- 1995-10-23 AT AT95934738T patent/ATE245629T1/de active
- 1995-10-23 EP EP95934738A patent/EP0788480B1/en not_active Expired - Lifetime
1997
- 1997-04-22 FI FI971711A patent/FI117438B/fi not_active IP Right Cessation
- 1997-04-24 NO NO971903A patent/NO309266B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT788480E (pt)	2003-12-31
MX9703024A (es)	1997-10-31
ES2202375T3 (es)	2004-04-01
EP0788480B1 (en)	2003-07-23
AU698637B2 (en)	1998-11-05
CA2200355C (en)	2007-03-06
NO309266B1 (no)	2001-01-08
JPH10507464A (ja)	1998-07-21
CA2200355A1 (en)	1996-05-02
FI971711L (fi)	1997-04-22
DE69531356T2 (de)	2004-05-27
HU227420B1 (en)	2011-05-30
HUT77631A (hu)	1998-06-29
PL319829A1 (en)	1997-09-01
DE69531356D1 (de)	2003-08-28
JP3911545B2 (ja)	2007-05-09
ATE245629T1 (de)	2003-08-15
PL183210B1 (pl)	2002-06-28
EP0788480A1 (en)	1997-08-13
US5994548A (en)	1999-11-30
NO971903D0 (no)	1997-04-24
FI117438B (fi)	2006-10-13
AU3704895A (en)	1996-05-15
FI971711A0 (fi)	1997-04-22
WO1996012699A1 (en)	1996-05-02
NO971903L (no)	1997-04-24

Publication	Publication Date	Title
DK0788480T3 (da)	2003-09-29	Krystallisering af levobupivacain og analoger deraf
ATE148130T1 (de)	1997-02-15	Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DK0584136T3 (da)	2000-05-22	Bestemmelse af peptidmotiver på MHC-molekyler
DK0788481T3 (da)	2003-12-01	Fremgangsmåde til fremstilling af levobupivacain og analoger deraf
DE69406522D1 (de)	1997-12-04	Verfahren zur Herstellung von alkalilöslichen Emulsionscopolymeren
DE69109401D1 (de)	1995-06-08	Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
DK0476113T3 (da)	1996-07-15	Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
NO20013128D0 (no)	2001-06-22	Sementblanding og fremgangsmåte dertil
DE59106800D1 (de)	1995-12-07	Verfahren zur Herstellung von Benzylketonen.
DE59204902D1 (de)	1996-02-15	Verfahren zur Herstellung von Diphenylaminen
DK0821588T3 (da)	2003-07-28	Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
DE59105224D1 (de)	1995-05-24	Verfahren zur Herstellung von N-substituierten Pyrrolidonen.
DK0687256T3 (da)	1998-03-30	Hydroxymethylfurazancarboxylsyrederivater og deresanvendelse ved behandling af kardiovaskulære sygdomme
DE59407675D1 (de)	1999-03-04	Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DK0586589T3 (da)	1997-09-22	Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
DK0620607T3 (da)	1998-02-23	Fremgangsmåde til elektrolytisk behandling af brugte batterier
ES2116089T3 (es)	1998-07-01	Elemento de bastidor.
ES2162078T3 (es)	2001-12-16	Compuestos terapeuticos.
DE58902228D1 (de)	1992-10-15	Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
DE69103913D1 (de)	1994-10-20	Verfahren zur Herstellung von Dodekandicarbonsäure.
NO881414D0 (no)	1988-03-29	Fremgangsmaate for behandling av spillvann og annet urent vann.
ATE131936T1 (de)	1996-01-15	Vorrichtung zur befestigung von zwei oder mehreren seismischen energiequellen an relativ fixierte positionen
ATE84780T1 (de)	1993-02-15	Neue di(meth)acrylate, verfahren zu deren herstellung und deren verwendung.
DE59200254D1 (de)	1994-07-28	Verfahren zur Herstellung von N-(Hydroxyalkyl)-carbamidsäure- alkylestern.
DE59106854D1 (de)	1995-12-14	Verfahren zur Herstellung von N-(2-Chlor-pyridin-5-yl-methyl)-ethylendiamin.